Comparison of Roche RIA, Roche EIA, Hybritech EIA, and Abbott EIA methods for measuring carcinoembryonic antigen Journal Article


Authors: Nisselbaum, J. S.; Smith, C. A.; Schwartz, D.; Schwartz, M. K.
Article Title: Comparison of Roche RIA, Roche EIA, Hybritech EIA, and Abbott EIA methods for measuring carcinoembryonic antigen
Abstract: Using 600 clinical specimens, we compared the concordance of four methods for carcinoembryonic antigen: the Roche RIA (I); the Roche EIA (II); Hybritech EIA (III); and Abbott EIA (IV). EDTA-treated plasma was used for Methods I and II and serum for Methods III and IV. However, no significant difference was found between results for serum and plasma in Method II. The normal reference interval (in μg/L) was I (222 specimens), 1.94 ± 1.54; II (57 specimens), 0.8 ± 0.5; III (100 specimens), 2.94 ± 2.47; and IV (614 specimens), <5.0. The precision of all four methods was acceptable. Concordance among all of the methods exceeded 90%.
Keywords: human cell; major clinical study; carcinoembryonic antigen; enzyme immunoassay; radioisotope; plasma; radioimmunoassay; male; female
Journal Title: Clinical Chemistry
Volume: 34
Issue: 4
ISSN: 0009-9147
Publisher: American Association for Clinical Chemistry  
Date Published: 1988-04-01
Start Page: 761
End Page: 764
Language: English
DOI: 10.1093/clinchem/34.4.761
PUBMED: 3282721
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 6 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Morton Schwartz
    186 Schwartz
  2. Carol   Smith
    39 Smith